Statistics
Publications
10
Citations
706
H-Index
10
Active since
2005
Rachna Kasliwal is an author at Drug Safety Research Unit specializing in pharmacotherapy, pharmacovigilance, and pharmacy.
Publications per year
2005–2020
10
10
Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing
Lana Zhovtis Ryerson, John Foley, Ih Chang et al. · Neurology · 2019 · 194 citations · Full text
Helmut Butzkueven, Ludwig Kappos, Heinz Wiendl et al. · Journal of Neurology Neurosurgery & Psychiatry · 2020 · 164 citations · Full text
Natalizumab in acute ischemic stroke (ACTION II)
Mitchell S.V. Elkind, Roland Veltkamp, Joan Montaner et al. · Neurology · 2020 · 103 citations · Full text
Medicine, Neurology, Pharmacotherapy +17
Safety Profile of Rosuvastatin
Rachna Kasliwal, Lynda V. Wilton, Victoria Cornelius et al. · Drug Safety · 2007 · 45 citations
1–5 of 10